Research. Advocacy. Support.
We advance ovarian cancer research while supporting women and their families.
Know Your Risks
About 20 to 25 percent of women diagnosed with ovarian cancer have a hereditary tendency to develop the disease.
Many factors can increase or decrease a woman's risk of developing ovarian cancer.
- Family history of breast, ovarian or colon cancer
- Genetic mutations like BRCA
- Increased age
- Use of oral contraceptives
Know the Symptoms
- Difficulty Eating
- Pelvic / Abdominal Pain
- Urinary Frequency
If these symptoms occur for more than 2 weeks and these symptoms are new or unusual for you, see a gynecologist and ask about ovarian cancer. Research shows that seeing a gynecologic oncologist for surgery and treatment significantly improves outcomes.
Spring Advocacy Day
OCRFA and our amazing advocates brought #TealAction to Capitol Hill on March 6, highlighting the need for increased ovarian cancer research funding and support at the federal level. Together, we are the voice of the ovarian cancer community.
Statement from OCRFA President & CEO Audra Moran on the Death of U.S. Representative Louise Slaughter
(March 16, 2018) On behalf of Ovarian Cancer Research Fund Alliance I want to extend our deepest condolences on the passing of U.S. Representative Louise Slaughter. As the author of the landmark Genetic Information Nondiscrimination Act (GINA), signed into law in 2008 after a 14-year battle, Representative Slaughter proved to be a tireless advocate for… More
Discovery of New Gene Mutation That Increases Ovarian Cancer Risk, Passed Down Through Paternal Lineage
(February 22, 2018) Researchers at Roswell Park Comprehensive Cancer Center, including Kunle Odunsi, MD, PhD, senior author of the study and current OCRFA Scientific Advisory Committee member, have discovered a mutation of an unidentified gene that increases both the risk of early onset ovarian cancer and prostate cancer. Using the Familial Ovarian Cancer Registry at… More
(February 14, 2018) Today the US Preventive Task Force updated their recommendation on ovarian cancer screening, reaffirming their 2012 position that screening average risk women for ovarian cancer is not effective in reducing mortality from the disease. Furthermore, they stated that screening for ovarian cancer carries certain risk and harms that may be substantial, and… More
OCRFA’s indoor cycling event returns to Atlanta on April 15, 2018. Ride with us to defeat ovar...April 15 @ 1:00 pm - 5:00 pm EDT
OCRFA’s indoor cycling event comes to San Mateo on April 22, 2018. Ride for a cure for ovarian...April 22 @ 1:00 pm - 2:00 pm PDT
OCRFA’s indoor cycling event returns to Chicago on April 22, 2018. Ride with us to defeat ovar...April 22 @ 2:30 pm - 4:30 pm CDT